2018-2023 Global Flu Vaccine (Influenza Vaccine) Consumption Market Report

Publisher Name :
Date: 18-Sep-2018
No. of pages: 133

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Flu Vaccine (Influenza Vaccine) market for 2018-2023.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.

Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.

The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.

Over the next five years, LPI(LP Information) projects that Flu Vaccine (Influenza Vaccine) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Flu Vaccine (Influenza Vaccine) market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Whole Virus Vaccines

- Split Virus Vaccines

- Subunit Vaccines

- Live Attenuated Virus Vaccines

Segmentation by application:

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- CSL

- GSK

- Sanofi Pasteur

- Mylan

- AstraZeneca

- Pfizer

- Johnson & Johnson

- ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Flu Vaccine (Influenza Vaccine) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Flu Vaccine (Influenza Vaccine) market by identifying its various subsegments.

- Focuses on the key global Flu Vaccine (Influenza Vaccine) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Flu Vaccine (Influenza Vaccine) with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Flu Vaccine (Influenza Vaccine) submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Flu Vaccine (Influenza Vaccine) Consumption Market Report

Table of Contents

2018-2023 Global Flu Vaccine (Influenza Vaccine) Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Flu Vaccine (Influenza Vaccine) Consumption 2013-2023
2.1.2 Flu Vaccine (Influenza Vaccine) Consumption CAGR by Region
2.2 Flu Vaccine (Influenza Vaccine) Segment by Type
2.2.1 Whole Virus Vaccines
2.2.2 Split Virus Vaccines
2.2.3 Subunit Vaccines
2.2.4 Live Attenuated Virus Vaccines
2.3 Flu Vaccine (Influenza Vaccine) Consumption by Type
2.3.1 Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2013-2018)
2.3.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2013-2018)
2.3.3 Global Flu Vaccine (Influenza Vaccine) Sale Price by Type (2013-2018)
2.4 Flu Vaccine (Influenza Vaccine) Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Flu Vaccine (Influenza Vaccine) Consumption by Application
2.5.1 Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2013-2018)
2.5.2 Global Flu Vaccine (Influenza Vaccine) Value and Market Share by Application (2013-2018)
2.5.3 Global Flu Vaccine (Influenza Vaccine) Sale Price by Application (2013-2018)

3 Global Flu Vaccine (Influenza Vaccine) by Players
3.1 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Players
3.1.1 Global Flu Vaccine (Influenza Vaccine) Sales by Players (2016-2018)
3.1.2 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Players (2016-2018)
3.2 Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Players
3.2.1 Global Flu Vaccine (Influenza Vaccine) Revenue by Players (2016-2018)
3.2.2 Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Players (2016-2018)
3.3 Global Flu Vaccine (Influenza Vaccine) Sale Price by Players
3.4 Global Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Flu Vaccine (Influenza Vaccine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Flu Vaccine (Influenza Vaccine) by Regions
4.1 Flu Vaccine (Influenza Vaccine) by Regions
4.1.1 Global Flu Vaccine (Influenza Vaccine) Consumption by Regions
4.1.2 Global Flu Vaccine (Influenza Vaccine) Value by Regions
4.2 Americas Flu Vaccine (Influenza Vaccine) Consumption Growth
4.3 APAC Flu Vaccine (Influenza Vaccine) Consumption Growth
4.4 Europe Flu Vaccine (Influenza Vaccine) Consumption Growth
4.5 Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Growth

5 Americas
5.1 Americas Flu Vaccine (Influenza Vaccine) Consumption by Countries
5.1.1 Americas Flu Vaccine (Influenza Vaccine) Consumption by Countries (2013-2018)
5.1.2 Americas Flu Vaccine (Influenza Vaccine) Value by Countries (2013-2018)
5.2 Americas Flu Vaccine (Influenza Vaccine) Consumption by Type
5.3 Americas Flu Vaccine (Influenza Vaccine) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Flu Vaccine (Influenza Vaccine) Consumption by Countries
6.1.1 APAC Flu Vaccine (Influenza Vaccine) Consumption by Countries (2013-2018)
6.1.2 APAC Flu Vaccine (Influenza Vaccine) Value by Countries (2013-2018)
6.2 APAC Flu Vaccine (Influenza Vaccine) Consumption by Type
6.3 APAC Flu Vaccine (Influenza Vaccine) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Flu Vaccine (Influenza Vaccine) by Countries
7.1.1 Europe Flu Vaccine (Influenza Vaccine) Consumption by Countries (2013-2018)
7.1.2 Europe Flu Vaccine (Influenza Vaccine) Value by Countries (2013-2018)
7.2 Europe Flu Vaccine (Influenza Vaccine) Consumption by Type
7.3 Europe Flu Vaccine (Influenza Vaccine) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Flu Vaccine (Influenza Vaccine) by Countries
8.1.1 Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Flu Vaccine (Influenza Vaccine) Value by Countries (2013-2018)
8.2 Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Type
8.3 Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Flu Vaccine (Influenza Vaccine) Distributors
10.3 Flu Vaccine (Influenza Vaccine) Customer

11 Global Flu Vaccine (Influenza Vaccine) Market Forecast
11.1 Global Flu Vaccine (Influenza Vaccine) Consumption Forecast (2018-2023)
11.2 Global Flu Vaccine (Influenza Vaccine) Forecast by Regions
11.2.1 Global Flu Vaccine (Influenza Vaccine) Forecast by Regions (2018-2023)
11.2.2 Global Flu Vaccine (Influenza Vaccine) Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Flu Vaccine (Influenza Vaccine) Forecast by Type
11.8 Global Flu Vaccine (Influenza Vaccine) Forecast by Application

12 Key Players Analysis
12.1 CSL
12.1.1 Company Details
12.1.2 Flu Vaccine (Influenza Vaccine) Product Offered
12.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 CSL News
12.2 GSK
12.2.1 Company Details
12.2.2 Flu Vaccine (Influenza Vaccine) Product Offered
12.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 GSK News
12.3 Sanofi Pasteur
12.3.1 Company Details
12.3.2 Flu Vaccine (Influenza Vaccine) Product Offered
12.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Sanofi Pasteur News
12.4 Mylan
12.4.1 Company Details
12.4.2 Flu Vaccine (Influenza Vaccine) Product Offered
12.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 AstraZeneca
12.5.1 Company Details
12.5.2 Flu Vaccine (Influenza Vaccine) Product Offered
12.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 AstraZeneca News
12.6 Pfizer
12.6.1 Company Details
12.6.2 Flu Vaccine (Influenza Vaccine) Product Offered
12.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Pfizer News
12.7 Johnson & Johnson
12.7.1 Company Details
12.7.2 Flu Vaccine (Influenza Vaccine) Product Offered
12.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Johnson & Johnson News
...

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Flu Vaccine (Influenza Vaccine)
Table Product Specifications of Flu Vaccine (Influenza Vaccine)
Figure Flu Vaccine (Influenza Vaccine) Report Years Considered
Figure Market Research Methodology
Figure Global Flu Vaccine (Influenza Vaccine) Consumption Growth Rate 2013-2023 (K Doses)
Figure Global Flu Vaccine (Influenza Vaccine) Value Growth Rate 2013-2023 ($ Millions)
Table Flu Vaccine (Influenza Vaccine) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Whole Virus Vaccines
Table Major Players of Whole Virus Vaccines
Figure Product Picture of Split Virus Vaccines
Table Major Players of Split Virus Vaccines
Figure Product Picture of Subunit Vaccines
Table Major Players of Subunit Vaccines
Figure Product Picture of Live Attenuated Virus Vaccines
Table Major Players of Live Attenuated Virus Vaccines
Table Global Consumption Sales by Type (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2013-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Type (2013-2018) ($ million)
Table Global Flu Vaccine (Influenza Vaccine) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Flu Vaccine (Influenza Vaccine) Value Market Share by Type (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sale Price by Type (2013-2018)
Figure Flu Vaccine (Influenza Vaccine) Consumed in For Children (6 months to 3 years)
Figure Global Flu Vaccine (Influenza Vaccine) Market: For Children (6 months to 3 years) (2013-2018) (K Doses)
Figure Global Flu Vaccine (Influenza Vaccine) Market: For Children (6 months to 3 years) (2013-2018) ($ Millions)
Figure Global For Children (6 months to 3 years) YoY Growth ($ Millions)
Figure Flu Vaccine (Influenza Vaccine) Consumed in For Adults and Children over 3 years
Figure Global Flu Vaccine (Influenza Vaccine) Market: For Adults and Children over 3 years (2013-2018) (K Doses)
Figure Global Flu Vaccine (Influenza Vaccine) Market: For Adults and Children over 3 years (2013-2018) ($ Millions)
Figure Global For Adults and Children over 3 years YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2013-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Value by Application (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Value Market Share by Application (2013-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Value Market Share by Application (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sale Price by Application (2013-2018)
Table Global Flu Vaccine (Influenza Vaccine) Sales by Players (2016-2018) (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Players (2016-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Players in 2016
Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Players in 2017
Table Global Flu Vaccine (Influenza Vaccine) Revenue by Players (2016-2018) ($ Millions)
Table Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Players (2016-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Players in 2016
Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Players in 2017
Table Global Flu Vaccine (Influenza Vaccine) Sale Price by Players (2016-2018)
Figure Global Flu Vaccine (Influenza Vaccine) Sale Price by Players in 2017
Table Global Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution and Sales Area by Players
Table Players Flu Vaccine (Influenza Vaccine) Products Offered
Table Flu Vaccine (Influenza Vaccine) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Flu Vaccine (Influenza Vaccine) Consumption by Regions 2013-2018 (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Regions 2013-2018
Figure Global Flu Vaccine (Influenza Vaccine) Consumption Market Share by Regions 2013-2018
Table Global Flu Vaccine (Influenza Vaccine) Value by Regions 2013-2018 ($ Millions)
Table Global Flu Vaccine (Influenza Vaccine) Value Market Share by Regions 2013-2018
Figure Global Flu Vaccine (Influenza Vaccine) Value Market Share by Regions 2013-2018
Figure Americas Flu Vaccine (Influenza Vaccine) Consumption 2013-2018 (K Doses)
Figure Americas Flu Vaccine (Influenza Vaccine) Value 2013-2018 ($ Millions)
Figure APAC Flu Vaccine (Influenza Vaccine) Consumption 2013-2018 (K Doses)
Figure APAC Flu Vaccine (Influenza Vaccine) Value 2013-2018 ($ Millions)
Figure Europe Flu Vaccine (Influenza Vaccine) Consumption 2013-2018 (K Doses)
Figure Europe Flu Vaccine (Influenza Vaccine) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption 2013-2018 (K Doses)
Figure Middle East & Africa Flu Vaccine (Influenza Vaccine) Value 2013-2018 ($ Millions)
Table Americas Flu Vaccine (Influenza Vaccine) Consumption by Countries (2013-2018) (K Doses)
Table Americas Flu Vaccine (Influenza Vaccine) Consumption Market Share by Countries (2013-2018)
Figure Americas Flu Vaccine (Influenza Vaccine) Consumption Market Share by Countries in 2017
Table Americas Flu Vaccine (Influenza Vaccine) Value by Countries (2013-2018) ($ Millions)
Table Americas Flu Vaccine (Influenza Vaccine) Value Market Share by Countries (2013-2018)
Figure Americas Flu Vaccine (Influenza Vaccine) Value Market Share by Countries in 2017
Table Americas Flu Vaccine (Influenza Vaccine) Consumption by Type (2013-2018) (K Doses)
Table Americas Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2013-2018)
Figure Americas Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type in 2017
Table Americas Flu Vaccine (Influenza Vaccine) Consumption by Application (2013-2018) (K Doses)
Table Americas Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2013-2018)
Figure Americas Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application in 2017
Figure United States Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure United States Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Canada Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Canada Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Mexico Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Mexico Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Table APAC Flu Vaccine (Influenza Vaccine) Consumption by Countries (2013-2018) (K Doses)
Table APAC Flu Vaccine (Influenza Vaccine) Consumption Market Share by Countries (2013-2018)
Figure APAC Flu Vaccine (Influenza Vaccine) Consumption Market Share by Countries in 2017
Table APAC Flu Vaccine (Influenza Vaccine) Value by Countries (2013-2018) ($ Millions)
Table APAC Flu Vaccine (Influenza Vaccine) Value Market Share by Countries (2013-2018)
Figure APAC Flu Vaccine (Influenza Vaccine) Value Market Share by Countries in 2017
Table APAC Flu Vaccine (Influenza Vaccine) Consumption by Type (2013-2018) (K Doses)
Table APAC Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2013-2018)
Figure APAC Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type in 2017
Table APAC Flu Vaccine (Influenza Vaccine) Consumption by Application (2013-2018) (K Doses)
Table APAC Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2013-2018)
Figure APAC Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application in 2017
Figure China Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure China Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Japan Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Japan Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Korea Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Korea Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Southeast Asia Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure India Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure India Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Australia Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Australia Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Table Europe Flu Vaccine (Influenza Vaccine) Consumption by Countries (2013-2018) (K Doses)
Table Europe Flu Vaccine (Influenza Vaccine) Consumption Market Share by Countries (2013-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Market Share by Countries in 2017
Table Europe Flu Vaccine (Influenza Vaccine) Value by Countries (2013-2018) ($ Millions)
Table Europe Flu Vaccine (Influenza Vaccine) Value Market Share by Countries (2013-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Value Market Share by Countries in 2017
Table Europe Flu Vaccine (Influenza Vaccine) Consumption by Type (2013-2018) (K Doses)
Table Europe Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2013-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type in 2017
Table Europe Flu Vaccine (Influenza Vaccine) Consumption by Application (2013-2018) (K Doses)
Table Europe Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2013-2018)
Figure Europe Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application in 2017
Figure Germany Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Germany Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure France Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure France Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure UK Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure UK Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Italy Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Italy Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Russia Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Russia Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Spain Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Spain Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Countries (2013-2018) (K Doses)
Table Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Market Share by Countries in 2017
Table Middle East & Africa Flu Vaccine (Influenza Vaccine) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Flu Vaccine (Influenza Vaccine) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Flu Vaccine (Influenza Vaccine) Value Market Share by Countries in 2017
Table Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Type (2013-2018) (K Doses)
Table Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Market Share by Type in 2017
Table Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption by Application (2013-2018) (K Doses)
Table Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption Market Share by Application in 2017
Figure Egypt Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Egypt Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure South Africa Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure South Africa Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Israel Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Israel Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure Turkey Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure Turkey Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Flu Vaccine (Influenza Vaccine) Consumption Growth 2013-2018 (K Doses)
Figure GCC Countries Flu Vaccine (Influenza Vaccine) Value Growth 2013-2018 ($ Millions)
Table Flu Vaccine (Influenza Vaccine) Distributors List
Table Flu Vaccine (Influenza Vaccine) Customer List
Figure Global Flu Vaccine (Influenza Vaccine) Consumption Growth Rate Forecast (2018-2023) (K Doses)
Figure Global Flu Vaccine (Influenza Vaccine) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Forecast by Countries (2018-2023) (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Market Forecast by Regions
Table Global Flu Vaccine (Influenza Vaccine) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Flu Vaccine (Influenza Vaccine) Value Market Share Forecast by Regions
Figure Americas Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Americas Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure APAC Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure APAC Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Europe Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Europe Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Middle East & Africa Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure United States Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure United States Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Canada Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Canada Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Mexico Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Mexico Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Brazil Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Brazil Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure China Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure China Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Japan Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Japan Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Korea Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Korea Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Southeast Asia Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Southeast Asia Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure India Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure India Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Australia Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Australia Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Germany Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Germany Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure France Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure France Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure UK Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure UK Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Italy Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Italy Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Russia Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Russia Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Spain Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Spain Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Egypt Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Egypt Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure South Africa Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure South Africa Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Israel Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Israel Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure Turkey Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure Turkey Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Figure GCC Countries Flu Vaccine (Influenza Vaccine) Consumption 2018-2023 (K Doses)
Figure GCC Countries Flu Vaccine (Influenza Vaccine) Value 2018-2023 ($ Millions)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Forecast by Type (2018-2023) (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Market Share Forecast by Type (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Flu Vaccine (Influenza Vaccine) Value Market Share Forecast by Type (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Forecast by Application (2018-2023) (K Doses)
Table Global Flu Vaccine (Influenza Vaccine) Consumption Market Share Forecast by Application (2018-2023)
Table Global Flu Vaccine (Influenza Vaccine) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Flu Vaccine (Influenza Vaccine) Value Market Share Forecast by Application (2018-2023)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Flu Vaccine (Influenza Vaccine) Market Share (2016-2018)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GSK Flu Vaccine (Influenza Vaccine) Market Share (2016-2018)
Table Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Flu Vaccine (Influenza Vaccine) Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Flu Vaccine (Influenza Vaccine) Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Flu Vaccine (Influenza Vaccine) Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Flu Vaccine (Influenza Vaccine) Market Share (2016-2018)
  • Global (United States, European Union and China) anti-HA Antibody Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 122
    Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called "antigens"). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler - scientists at the Roche-funded Basel Institute for Immunology - who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological researc......
  • Global (United States, European Union and China) Antiemetic Drugs Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 122
    An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer. The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the produ......
  • Global (United States, European Union and China) Valacyclovir Oral Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 122
    Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children. In 2019, the market size of Valacyclovir Oral is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase......
  • Global (United States, European Union and China) Prophy Paste Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 122
    Prophy pastes for oral health treatments designed to be effective and kind on natural teeth and restorations. In 2019, the market size of Prophy Paste is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast ......
  • Global (United States, European Union and China) Human Embryonic Stem Cells (HESC) Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 122
    Human embryonic stem cell: also known as a human pluripotent stem cell, one of the "cells that are self-replicating, are derived from human embryos or human fetal tissue, and are known to develop into cells and tissues of the three primary germ layers. In 2019, the market size of Human Embryonic Stem Cells (HESC) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to x......
  • Global (United States, European Union and China) Heart Failure Therapeutics Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 122
    Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart fai......
  • Global (United States, European Union and China) Cancer Janus Kinase Inhibitors Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 122
    Cancer Janus Kinase Inhibitors The conventional modes of cancer management including surgery, radiotherapy and chemotherapy were discarded as an aspirant for the future of cancer management long back ago. The arrival of modern cancer treatment modalities like immunotherapy and targeted therapy revolutionized the outlook of the future of cancer management. Amongst both of the modern therapies, targeted therapies have shown an impressive growth in a very short duration of time. The targeted......
  • Global (United States, European Union and China) Cancer Drug Therapy Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 121
    Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs. The renal cancer drug therapy market has witnessed a dramatic change in its treatment ......
  • Global (United States, European Union and China) Valsartan-Hydrochlorothiazide Market Research Report 2019-2025
    Published: 23-Aug-2019        Price: US 3280 Onwards        Pages: 121
    This drug is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: valsartan and hydrochlorothiazide. Valsartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a "water pill" (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water. In 2019, the market ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs